李曄雄，博士，籍貫湖南，腫瘤放療專(zhuān)家。中國(guó)醫(yī)學(xué)科學(xué)院協(xié)和醫(yī)科大學(xué)腫瘤醫(yī)院教授、主任醫(yī)師，博士生導(dǎo)師。1984年湖南醫(yī)科大學(xué)醫(yī)療系畢業(yè)獲得學(xué)士學(xué)位，1990年獲中國(guó)協(xié)和醫(yī)科大學(xué)放射腫瘤學(xué)碩士學(xué)位，1997年獲瑞士洛桑大學(xué)放射腫瘤學(xué)博士學(xué)位，1998年在美國(guó)德克薩斯大學(xué)M.D. Anderson癌癥中心從事博士后研究。2003年起聘任正高，2020年為協(xié)和長(zhǎng)聘教授。2000年任科主任。一直從事放射腫瘤學(xué)臨床和轉(zhuǎn)化研究。

主要研究領(lǐng)域?yàn)閻盒阅[瘤的放療，開(kāi)展和應(yīng)用最先進(jìn)放療技術(shù)，改進(jìn)治療方法，著重探索淋巴瘤臨床病理和生物學(xué)特征，建立風(fēng)險(xiǎn)分層治療原則和放療指南，建立乳腺癌術(shù)后短療程大分割照射方案等，居國(guó)際領(lǐng)先水平。

午夜92福利1000,午夜92福利1000,久久国产亚洲高清观看5388,美女不拍网站免费观看,欧美***天天久久综合精品,中文字幕日韩系列中文字幕,综合久久国产九一剧情麻豆,丰满人妻在线免费视频,奶子大逼又嫩操起来真爽

1. Jin J#*, Tang Y#, Hu C, Jiang LM, Jiang J, Li N, Liu WY, Chen SL, Li H, Lu NN, Cai Y, Li YH, Zhu Y, Cheng GH, Zhang HY, Wang X, Zhu SY, Wang J, Li GF, Yang JL, Zhang K, Chi Y, Yang L, Zhang HZ, Zhou ZX, Zhou AP, Zou SM, Fang H, Wang SL, Zhang HZ*, Wang XS*, Wei LC*, Wang WL*, Liu SX*, Gao YH*, Li YX*. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022, 40:1681-1692. (IF=50.717, PIII)

2. Chen B#, Wu JX#, Cheng SH, Wang LM, Rong WQ,Wu F, Wang SL, Jin J, Liu YP, Song YW, Ren H, Fang H, Tang Y, Li N, Li YX*, Wang WH*. Phase 2 study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma. Hepatol. 2021, 74(5):2595-2604. (IF=17.298)

3. Wang SL# Fang F#, Hu C, Song YW, Wang WH, Jin J, Liu YP, Ren H, Liu J, Li GF, Du XH, Hui X, Tang Y, Jing H, Ma YC, Huang Z, Chen B, Tang Y, Li N, Lu NN, Qi SN, Yang Y, Sun GY, Liu XF, Li YX*. Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: a multicentre randomized controlled trial from China. J Clin Oncol. 2020, 38:3604-3614. (IF=44.544, PIII, R)

4. Wang SL#, Fang H#, Song YW, Wang WH, Hu C, Liu YP, Jin J, Liu XF, Yu ZH, Ren H, Li N, Lu NN, Tang Y, Tang Y, Qi SN, Sun GY, Peng R, Li S, Chen B, Yang Y, Li YX*. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for high-risk breast cancer patients: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019, 20:352-360. (IF=32.277, PIII, ESI, R)

5. Yang Y#, Cao JZ#, Lan SM, Wu JX, Wu T, Zhu SY, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Xu LM, Yuan ZY, Qi SN, and Li YX*. Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type NK/T-cell lymphoma. JAMA Oncol. 2017, 3(1):83-91. (IF=16.559)

6. Yang Y#, Zhu Y#, Cao JZ, Zhang YJ, Xu LM, Yuan ZY, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, and Li YX*. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. Blood. 2015, 126(12):1424-1432. (IF=9.762)

7. Wang ZY#, Liu QF, Wang H, Jin J, Wang WH, Wang SL, Song YW, Liu YP, Fang H, Ren H, Wu RY, Chen B, Zhang XM, Lu NN, Zhou LQ, Li YX*. Clinical implications of plasma Epstein-Barr virus DNA in early-stage extra nodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy. Blood. 2012, 120(10):2003-2010. (IF=10.337)

8. Wang ZY#, Li YX*, Wang WH, Jin J, Wang H, Song YW, Liu QF, Wang SL, Liu YP, Qi SN, Fang H, Liu XF, and Yu ZH. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood. 2009, 114(23):4771-4776. (IF=10.566, R)

9. Li YX*#, Fang H, Liu QF, Lu J, Qi SN, Wang H, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Feng XL, and Yu ZH. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood. 2008, 112(8):3057-3064. (IF=10.466, R)

10. Li YX*#, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, and Yu ZH. Radiotherapy as primary treatment for stage IE and IIE nasal NK/T-cell lymphoma. J Clin Oncol. 2006, 24(1):181-189. (IF=10.863, C100, R)